Cite
Clinical Efficacy and Safety of Artesimia annua-Sublingual Immunotherapy in Seasonal Allergic Rhinitis Patients Based on Different Intervention Time.
MLA
Yang, Jiayi, et al. “Clinical Efficacy and Safety of Artesimia Annua-Sublingual Immunotherapy in Seasonal Allergic Rhinitis Patients Based on Different Intervention Time.” International Archives of Allergy & Immunology, vol. 183, no. 8, Aug. 2022, pp. 852–59. EBSCOhost, https://doi.org/10.1159/000524108.
APA
Yang, J., Shen, Z., Liu, L., Kang, W., Shao, Y., Zhang, P., & Quan, F. (2022). Clinical Efficacy and Safety of Artesimia annua-Sublingual Immunotherapy in Seasonal Allergic Rhinitis Patients Based on Different Intervention Time. International Archives of Allergy & Immunology, 183(8), 852–859. https://doi.org/10.1159/000524108
Chicago
Yang, Jiayi, Zhen Shen, Lifeng Liu, Wei Kang, Yuan Shao, Pengfei Zhang, and Fang Quan. 2022. “Clinical Efficacy and Safety of Artesimia Annua-Sublingual Immunotherapy in Seasonal Allergic Rhinitis Patients Based on Different Intervention Time.” International Archives of Allergy & Immunology 183 (8): 852–59. doi:10.1159/000524108.